Palatin Techs Stock (AMEX: PTN) stock price, news, charts, stock research, profile.
Open | $1.880 |
Close | $1.900 |
Volume / Avg. | 234.274K / 703.741K |
Day Range | 1.820 - 1.944 |
52 Wk Range | 1.430 - 5.650 |
Market Cap | $30.660M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 49 |
Short Interest | 9.2% |
Days to Cover | 6.88 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Palatin Techs (AMEX: PTN) through any online brokerage.
Other companies in Palatin Techs’s space includes: NKGen Biotech (NASDAQ:NKGN), CERo Therapeutics Hldgs (NASDAQ:CERO), Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO) and Acurx Pharmaceuticals (NASDAQ:ACXP).
The latest price target for Palatin Techs (AMEX: PTN) was reported by HC Wainwright & Co. on Wednesday, February 28, 2024. The analyst firm set a price target for 17.00 expecting PTN to rise to within 12 months (a possible 794.74% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Palatin Techs (AMEX: PTN) is $1.9 last updated April 17, 2024 at 6:59 PM EDT.
There are no upcoming dividends for Palatin Techs.
Palatin Techs’s Q3 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for Palatin Techs.
Palatin Techs is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.